# CNRIP1

## Overview
CNRIP1 is a gene that encodes the cannabinoid receptor interacting protein 1 (CRIP1), which is involved in the modulation of cannabinoid receptor signaling. The protein primarily interacts with the CB1 cannabinoid receptor (CB1R), a G protein-coupled receptor, influencing its signaling pathways and affecting various physiological processes. CRIP1a, a prominent isoform of the protein, is characterized by a unique β-barrel structure and is involved in the regulation of G-protein coupling and receptor trafficking. This protein plays a crucial role in modulating cellular signaling pathways, including those related to cyclic adenosine monophosphate (cAMP) and extracellular signal-regulated kinase (ERK) phosphorylation, which are vital for cellular communication and function (Booth2021Cannabinoid; Oliver2020Cannabinoid). CNRIP1 has been implicated in several clinical conditions, including cancer and neurological disorders, where its expression and methylation status serve as potential biomarkers for disease prognosis and treatment response (Zhang2017Value; Oliver2020Cannabinoid).

## Structure
The Cannabinoid Receptor Interacting Protein 1a (CRIP1a), encoded by the CNRIP1 gene, exhibits a unique molecular structure characterized by a 10-stranded antiparallel β-barrel with a distinctive gap between strands β8 and β10. This structure is closed by a hydrogen-bonding network involving residues such as Trp121, Tyr145, Thr119, and Glu161, and is lined with conserved residues that form a hydrophobic core (Booth2021Cannabinoid). CRIP1a is homologous to a family of lipidated-protein carriers, suggesting it may transport lipidated cargo, such as myristoylated peptides, which it binds with specificity (Booth2021Cannabinoid).

CRIP1a is predominantly composed of β-sheets and loops, classifying it as an all β protein (Ahmed2014Predicting). The protein shares structural homology with Rho-GDI2, which also features a β-barrel fold, indicating potential functional similarities in lipid binding (Ahmed2017The). CRIP1a has a palmitoylation site and a PDZ class I ligand domain, which may influence its localization and interaction with other proteins (Ahmed2017The). The protein exists in different isoforms, such as CRIP1b, which lacks the unique gapped β-barrel structure found in CRIP1a (Booth2021Cannabinoid).

## Function
Cannabinoid receptor interacting protein 1a (CRIP1a) plays a significant role in modulating the signaling pathways of the CB1 cannabinoid receptor (CB1R), a G protein-coupled receptor predominantly found in the central nervous system. CRIP1a influences the preference of CB1R for different G protein subtypes, switching from Gi3 and Go to Gi1 and Gi2, which can alter downstream signaling cascades (Oliver2020Cannabinoid; Blume2015Cannabinoid). This modulation affects various cellular processes, including the regulation of cyclic adenosine monophosphate (cAMP) levels and extracellular signal-regulated kinase (ERK) phosphorylation, which are crucial for cellular signaling (Booth2019Cannabinoid).

CRIP1a also plays a role in the trafficking of CB1R by attenuating agonist-induced internalization and affecting β-arrestin recruitment, which is essential for receptor desensitization and internalization (Booth2019Cannabinoid; Oliver2020Cannabinoid). This interaction is influenced by the phosphorylation state of CB1R, suggesting that CRIP1a modulates β-arrestin recruitment in a phosphorylation-dependent manner (Booth2019Cannabinoid). Through these mechanisms, CRIP1a contributes to the fine-tuning of CB1R signaling, impacting physiological functions such as energy storage, cardiovascular regulation, and neuroprotection (Oliver2020Cannabinoid).

## Clinical Significance
CNRIP1 has been implicated in various diseases, particularly cancers and neurological disorders. In cancer, CNRIP1 expression is inversely correlated with ABCC3 in glioma, affecting survival rates (Oliver2020Cannabinoid). Hypermethylation of the CNRIP1 promoter is a biomarker for colorectal cancer, correlating with reduced mRNA and protein levels, and is observed in other cancers such as cholangiocarcinoma, lung adenocarcinoma, non-Hodgkin lymphoma, and gastric carcinoma (Oliver2020Cannabinoid). Demethylation treatments increase CNRIP1 expression, suggesting its role as a tumor suppressor (Zhang2017Value; Oliver2020Cannabinoid). In colorectal cancer, CNRIP1 promoter methylation is associated with tumor characteristics and can serve as a biomarker for early detection and prognosis (Zhang2017Value; Lind2011Identification).

In neurological conditions, CNRIP1 is linked to epilepsy and schizophrenia. In epilepsy, lower expression levels of CRIP1a are observed in patients with therapy-resistant temporal lobe epilepsy (Oliver2020Cannabinoid). In schizophrenia, decreased methylation of the CNRIP1 promoter is associated with increased CRIP1a expression, suggesting a role in genetic predisposition to the disorder (Oliver2020Cannabinoid). These findings highlight the clinical significance of CNRIP1 in various diseases.

## Interactions
CNRIP1, encoding the Cannabinoid Receptor Interacting Protein 1, primarily interacts with the cannabinoid receptor CB1 (CB1R). CRIP1a, one of the protein isoforms encoded by CNRIP1, binds to the C-terminal tail of CB1R, modulating its signaling pathways. This interaction is crucial for regulating CB1R-mediated G-protein activity, as CRIP1a can attenuate both constitutive and agonist-stimulated CB1R-mediated G-protein activation (Smith2015Cannabinoid). CRIP1a's interaction with CB1R is specific to the last nine amino acids of the CB1R C-terminus (Niehaus2007CB1).

CRIP1a also interacts with the Gαi protein, specifically binding to an N-terminally myristoylated peptide mimicking the Gαi N terminus. This interaction suggests a role for CRIP1a in modulating CB1R's G-protein coupling by altering selectivity for Gαi subtype activation (Booth2021Cannabinoid). Additionally, CRIP1a has been shown to interact with synaptic proteins, indicating its presence in both excitatory and inhibitory terminals, which suggests a presynaptic localization (Guggenhuber2015Cannabinoid).

In the context of schizophrenia, CNRIP1 overexpression in the ventral hippocampus of rodents has been associated with altered dopamine neuron activity, although the exact mechanism of interaction with dopamine-related proteins remains unclear (Perez2019Ventral).


## References


[1. (Booth2019Cannabinoid) William T. Booth, Noah B. Walker, W. Todd Lowther, and Allyn C. Howlett. Cannabinoid receptor interacting protein 1a (crip1a): function and structure. Molecules, 24(20):3672, October 2019. URL: http://dx.doi.org/10.3390/molecules24203672, doi:10.3390/molecules24203672. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/molecules24203672)

[2. (Ahmed2017The) M.H. Ahmed and Y. Zhang. The Protein–Protein Interactions of Cannabinoid Receptor Interacting Protein 1a (CRIP1a) and Cannabinoid 1 Receptor: The Molecular Mechanism Study Through an Integrated Molecular Modeling Approach, pages 680–690. Elsevier, 2017. URL: http://dx.doi.org/10.1016/b978-0-12-800756-3.00081-8, doi:10.1016/b978-0-12-800756-3.00081-8. This article has 0 citations.](https://doi.org/10.1016/b978-0-12-800756-3.00081-8)

[3. (Booth2021Cannabinoid) William T. Booth, Jill E. Clodfelter, Sandra Leone-Kabler, Erin K. Hughes, Khalil Eldeeb, Allyn C. Howlett, and W. Todd Lowther. Cannabinoid receptor interacting protein 1a interacts with myristoylated gαi n terminus via a unique gapped β-barrel structure. Journal of Biological Chemistry, 297(3):101099, September 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.101099, doi:10.1016/j.jbc.2021.101099. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.101099)

[4. (Ahmed2014Predicting) Mostafa H. Ahmed, Glen E. Kellogg, Dana E. Selley, Martin K. Safo, and Yan Zhang. Predicting the molecular interactions of crip1a–cannabinoid 1 receptor with integrated molecular modeling approaches. Bioorganic &amp; Medicinal Chemistry Letters, 24(4):1158–1165, February 2014. URL: http://dx.doi.org/10.1016/j.bmcl.2013.12.119, doi:10.1016/j.bmcl.2013.12.119. This article has 13 citations.](https://doi.org/10.1016/j.bmcl.2013.12.119)

[5. (Zhang2017Value) Ting Zhang, Ge Cui, Yun-Liang Yao, Qi-Chun Wang, Hong-Guang Gu, Xi-Ning Li, Hui Zhang, Wen-Ming Feng, Qi-Lin Shi, and Weiwei Cui. Value of cnrip1 promoter methylation in colorectal cancer screening and prognosis assessment and its influence on the activity of cancer cells. Archives of Medical Science, 6:1281–1294, 2017. URL: http://dx.doi.org/10.5114/aoms.2017.65829, doi:10.5114/aoms.2017.65829. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.5114/aoms.2017.65829)

[6. (Guggenhuber2015Cannabinoid) Stephan Guggenhuber, Alan Alpar, Rongqing Chen, Nina Schmitz, Melanie Wickert, Tobias Mattheus, Anne E. Harasta, Martin Purrio, Nadine Kaiser, Maurice R. Elphick, Krisztina Monory, Werner Kilb, Heiko J. Luhmann, Tibor Harkany, Beat Lutz, and Matthias Klugmann. Cannabinoid receptor-interacting protein crip1a modulates cb1 receptor signaling in mouse hippocampus. Brain Structure and Function, 221(4):2061–2074, March 2015. URL: http://dx.doi.org/10.1007/s00429-015-1027-6, doi:10.1007/s00429-015-1027-6. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00429-015-1027-6)

[7. (Smith2015Cannabinoid) Tricia H. Smith, Lawrence C. Blume, Alex Straiker, Jordan O. Cox, Bethany G. David, Julie R. Secor McVoy, Katherine W. Sayers, Justin L. Poklis, Rehab A. Abdullah, Michaela Egertová, Ching-Kang Chen, Ken Mackie, Maurice R. Elphick, Allyn C. Howlett, and Dana E. Selley. Cannabinoid receptor–interacting protein 1a modulates cb1 receptor signaling and regulation. Molecular Pharmacology, 87(4):747–765, February 2015. URL: http://dx.doi.org/10.1124/mol.114.096495, doi:10.1124/mol.114.096495. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.114.096495)

[8. (Perez2019Ventral) Stephanie M. Perez, Jennifer J. Donegan, Angela M. Boley, David D. Aguilar, Andrea Giuffrida, and Daniel J. Lodge. Ventral hippocampal overexpression of cannabinoid receptor interacting protein 1 (cnrip1) produces a schizophrenia-like phenotype in the rat. Schizophrenia Research, 206:263–270, April 2019. URL: http://dx.doi.org/10.1016/j.schres.2018.11.006, doi:10.1016/j.schres.2018.11.006. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.schres.2018.11.006)

[9. (Niehaus2007CB1) Jason L. Niehaus, Yunguang Liu, Kathleen T. Wallis, Michaela Egertová, Sheela G. Bhartur, Somnath Mukhopadhyay, Shanping Shi, Hengjun He, Dana E. Selley, Allyn C. Howlett, Maurice R. Elphick, and Deborah L. Lewis. Cb1 cannabinoid receptor activity is modulated by the cannabinoid receptor interacting protein crip 1a. Molecular Pharmacology, 72(6):1557–1566, September 2007. URL: http://dx.doi.org/10.1124/mol.107.039263, doi:10.1124/mol.107.039263. This article has 105 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1124/mol.107.039263)

[10. (Oliver2020Cannabinoid) Emily E. Oliver, Erin K. Hughes, Meaghan K. Puckett, Rong Chen, W. Todd Lowther, and Allyn C. Howlett. Cannabinoid receptor interacting protein 1a (crip1a) in health and disease. Biomolecules, 10(12):1609, November 2020. URL: http://dx.doi.org/10.3390/biom10121609, doi:10.3390/biom10121609. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom10121609)

[11. (Lind2011Identification) Guro E Lind, Stine A Danielsen, Terje Ahlquist, Marianne A Merok, Kim Andresen, Rolf I Skotheim, Merete Hektoen, Torleiv O Rognum, Gunn I Meling, Geir Hoff, Michael Bretthauer, Espen Thiis-Evensen, Arild Nesbakken, and Ragnhild A Lothe. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Molecular Cancer, July 2011. URL: http://dx.doi.org/10.1186/1476-4598-10-85, doi:10.1186/1476-4598-10-85. This article has 106 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-10-85)

[12. (Blume2015Cannabinoid) Lawrence C. Blume, Khalil Eldeeb, Caroline E. Bass, Dana E. Selley, and Allyn C. Howlett. Cannabinoid receptor interacting protein (crip1a) attenuates cb1r signaling in neuronal cells. Cellular Signalling, 27(3):716–726, March 2015. URL: http://dx.doi.org/10.1016/j.cellsig.2014.11.006, doi:10.1016/j.cellsig.2014.11.006. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2014.11.006)